BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 69168)

  • 1. Epipodophylin derivative (VP 16-23) in malignant teratomas and choriocarcinomas.
    Newlands ES; Bagshawe KD
    Lancet; 1977 Jul; 2(8028):87. PubMed ID: 69168
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-tumour activity of the epipodophyllin derivative VP16-213 (etoposide: NSC-141540) in gestational choriocarcinoma.
    Newlands ES; Bagshawe KD
    Eur J Cancer (1965); 1980 Mar; 16(3):401-5. PubMed ID: 6154579
    [No Abstract]   [Full Text] [Related]  

  • 3. VP-16 in combinations for first-line treatment of malignant germ-cell tumors and gestational choriocarcinoma.
    Newlands ES
    Semin Oncol; 1985 Mar; 12(1 Suppl 2):37-41. PubMed ID: 2579442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Etoposide. A new highly effective cytostatic agent in anaplastic small-cell bronchial carcinoma, other solid tumors and hemoblastoses].
    Goldhirsch A; Joss R; Cavalli F; Sonntag RW; Ryssel HJ; Brunner KW
    Dtsch Med Wochenschr; 1981 Aug; 106(35):1105-9. PubMed ID: 6266800
    [No Abstract]   [Full Text] [Related]  

  • 5. Epipodophyllin derivative (VP 16-213) in treatment of solid tumours.
    Cavalli F; Sonntag RW; Brunner KW
    Lancet; 1977 Aug; 2(8033):362. PubMed ID: 69974
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of VP16-213 (etoposide; NSC-141540) in gestational choriocarcinoma.
    Newlands ES; Bagshawe KD
    Cancer Chemother Pharmacol; 1982; 7(2-3):211-4. PubMed ID: 7083462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etoposide.
    N Engl J Med; 1985 Aug; 313(8):518-9. PubMed ID: 2991763
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics and toxicity of the epipodophyllotoxin derivative etoposide (VP 16-213) in patients with gestational choriocarcinoma and malignant teratoma.
    Brindley CJ; Antoniw P; Newlands ES; Bagshawe KD
    Cancer Chemother Pharmacol; 1985; 15(1):66-71. PubMed ID: 4039984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of etoposide in gestochoriocarcinoma.
    D'Incalci M; Sessa C; Rossi C; Roviaro G; Mangioni C
    Cancer Treat Rep; 1985 Jan; 69(1):69-72. PubMed ID: 2981622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of oral VP-16-213 in non-seminomatous testicular cancer.
    Cavalli F; Klepp O; Renard J; Röhrt M; Alberto P
    Eur J Cancer (1965); 1981 Feb; 17(2):245-9. PubMed ID: 7262161
    [No Abstract]   [Full Text] [Related]  

  • 11. High-dose VP-16-213 monotherapy for refractory germinal malignancies: a phase II study.
    Wolff SN; Johnson DH; Hainsworth JD; Greco FA
    J Clin Oncol; 1984 Apr; 2(4):271-4. PubMed ID: 6368760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [VM-26 and VP-16 salvage therapy for refractory germinal testicular cancers].
    Miki T; Tomooka Y; Yoshimura K; Maeda O; Saiki S; Kinouchi T; Kuroda M; Usami M; Kotake T
    Nihon Hinyokika Gakkai Zasshi; 1989 Nov; 80(11):1609-16. PubMed ID: 2593435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral etoposide in gestational trophoblastic disease.
    Wong LC; Choo YC; Ma HK
    Cancer Treat Rep; 1984 May; 68(5):775-7. PubMed ID: 6327035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of etoposide in the management of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
    Slayton RE; Blessing JA; Delgado G
    Cancer Treat Rep; 1982 Aug; 66(8):1669-71. PubMed ID: 7105059
    [No Abstract]   [Full Text] [Related]  

  • 15. [A case of complete remission obtained with etoposide in uterine choriocarcinoma].
    Kikuchi J; Sasaki T; Ishibashi K; Takaya R; Mori H; Endo H; Shima I; Moritsuka T; Takahashi K
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1209-12. PubMed ID: 2053779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Basic and clinical study of anticancer effect of etoposide on choriocarcinoma].
    Fujii T; Maeda M
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 May; 40(5):593-600. PubMed ID: 3385278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer.
    Loehrer PJ; Einhorn LH; Williams SD
    J Clin Oncol; 1986 Apr; 4(4):528-36. PubMed ID: 3633952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity and distribution studies of etoposide and mitozolomide in vivo and in vitro against human choriocarcinoma cell lines.
    Brindley CJ; Pedley RB; Antoniw P; Newlands ES
    Cancer Chemother Pharmacol; 1987; 19(3):221-5. PubMed ID: 3581415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticancer effect of VP16-213 (etoposide) on three choriocarcinoma cell lines].
    Matsui H; Kobayashi O; Shirotake S; Sekiya S; Takamizawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jun; 39(6):933-9. PubMed ID: 3611870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VP16-213 as a single agent in advanced testicular tumors.
    Fitzharris BM; Kaye SB; Saverymuttu S; Newlands ES; Barrett A; Peckham MJ; McElwain TJ
    Eur J Cancer (1965); 1980 Sep; 16(9):1193-7. PubMed ID: 7227446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.